Showing posts from August, 2015

Concussion Leads to Dementia If Neglected

Concussion Leads to Dementia If Neglected Football faces hundreds of lawsuits from players with dementia caused by concussions. That's because new research shows damage to the brain can persist for decades after a head trauma. Learn why. Find out what to do.

"Even when you are symptom-free, your brain may still not be back to normal," says Dr. Maryse Lassonde, a neuropsychologist and the scientific director of the Quebec Nature and Technologies Granting Agency.

Lassonde, whose work is supported by the Canada Foundation for Innovation, was a consultant with the Montreal Canadiens hockey team, treating players with concussions for 15 years. She simultaneously undertook research into the effects of concussions on children and young athletes as well as older athletes.

A concussion is traumatic brain injury that changes the way your brain functions. When the skull is jolted or impacted by a hard surface, the brain shifts, slamming against the skull, causing damage and swellin…

The dementia epidemic: is it really stabilising?

The dementia epidemic: is it really stabilising? A new study suggests that dementia rates aren't increasing, but if we take a look at the age of those studied, the living conditions of those born pre and post-war plays a huge role. As younger generations become less healthy, it is likely to increase in the future NAAHEED MUKADAM Monday 24 August 2015

Scientists find first drug that appears to slow Alzheimer's disease

Scientists find first drug that appears to slow Alzheimer's disease
Solanezumab blocks memory loss in patients with mild version of the disease, making it the first medicine ever to slow pace of damage to patients’ brains
Dr Matthew Norton, head of policy at Alzheimer’s Research UK, welcomes a new drug that slows the pace of mental decline

Scientists appear to have broken a decades-long deadlock in the battle against Alzheimer’s disease after announcing trial results for the first drug that appears to slow the pace of mental decline.
The drug, called solanezumab, was shown to stave off memory loss in patients with mild Alzheimer’s over the course of several years. The effects would have been barely discernible to patients or their families, scientists said, and it is no cure. But the wider implications of the results have been hailed as “hugely significant” because it is the first time any medicine has slowed the rate at which the disease damages the brain.
“This is the first evidence …

Last Newsletter from Richard Taylor

I received this yesterday, and decided that as Richard was so well admired and loved by thousands of people around the world, that I would share it with you. Richard will be sadly missed by many. I know that many friends are taking part in an online remembrance project, tomorrow, but due to a hospital appointment, I will not be able to take part  

To  All: I could never thank all of you enough for all the kind words you have sent to our family about Richard. Many of you have sent the most amazing stories about how you met Richard, projects you worked on, and even how he touched your lives in his own unique way. That was the Richard I grew up knowing. As promised I am sending out the last newsletter Richard started. I am going to send it out exactly as he left it and hope this will still provide everyone some helpful information. So apologies in advance for the lack of editing. In the near future I will have to close down Richard's E-mail account. I know some of you still have a few …